Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LIPD: SEC Suspension:
http://www.sec.gov/litigation/suspensions/2013/34-69617.pdf
Order:
http://www.sec.gov/litigation/suspensions/2013/34-69617-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2013/34-69618.pdf
$LIPD @ .0036!
Would be nice if LIPD would make some public announcements. Share structure is such that with a little volume and LIPD ends up in Penny Land with-in minutes.
Lipid Sciences, Inc. - Financial and Strategic Analysis Review
By: Global Markets Direct, Published: Apr-2009 Report Code: GMDPH61184FSAS
Description
Lipid Sciences, Inc. is a development-stage biotechnology company principally engaged in the research and development of therapeutics for cardiovascular disease based on its HDL therapy platform (HDL Mimetic Peptides and HDL selective delipidation) and viral infections based on its viral immunotherapy platform. The company is headquartered in Pleasanton, California, United States and employs 17 people.
Global Markets Direct’s Lipid Sciences, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Lipid Sciences, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
Provides key company information for business intelligence needs.
The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios
LIPD closed at .0025 with a decent gain of 47%. With some volume this ultra low floater can become SUPER EXPLOSIVE , or any type of positive filings or someone putting an alert on LIPD. Currently I am holding LIPD at a small loss, but that will soon change.
You've seen Penny stocks explode by 1000's of % with-in minutes, well, LIPD is one of those GEMS. Play LIPD as you see fit.
Good Luck
LIPD @ .0037!
LIPD @ .0033!
LIPD @ .0024!
LIPD @ .0019!
Somebody is slowly and steadily buying. Something is definetely in the works.
Wow, whats in the works. Somebody is buying and with decent volume.
dont know, sorry 4 the late response, got in trouble with ihub...sent me to the jail of i hub...lol
will try a buy monday, stay low for now i hope!
along with
fbtxq
some1s buying well over asking, i know cause i sold it to them, ithink they know sumthig i donot
is this going to dollars? other pharma plays WFHCQ ARGA RXEI similar to this
No doubt!
something must be going on with this one, not sure who's buying
good bargin for a cent or 2!
even better, never got; nor needed the Q
odd day, biotech was hot today except this one
Not me
ask damn thin man !! hold tight your shares !
.02 nite
.03 etmm
.05 hdsn
.25 doms, pert
gl
chart on its way to .10--->
is there a buyout coming?
i played with this stock last year. i liked it for a bit. i have a strong feeling this stock will be at what it was at the beginning of 2008. i hold a bit in this company right now. i am waiting for a certain date and where it may be at then to purchase more.
interesting upticks, I wonder who's buying and what's going on
I'd like that, 200ma at .10
The gap should be filled to .06
3 now
1smart, you
1stupid ,me
1 from the buyer
i hope it goes to $$$$ for you !!
2 bm from us both lol
Y, some1 know somehing ,,,
quiet mover.
Only 2 boardmarks ,1= mine,,without shares ,grrrrrrrrr
gl
maybe someone got a hold of it and decided to accumulate shares =)
Grrrrrrrrrr thats about $ 700
do you have 399 british pounds? http://www.tradingmarkets.com/.site/news/Stock%20News/2224508/
the cost of the report
thats sux man.
I didn't buy a lot when I created this board =(
WOW ,not me and not ihub !!!!
http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=lipd
never booth , damn !!
I hope you got i boatload !you deserve it man,gl
who's buying?
01
009 x 01 1 x2 nite x hdsn, nite
next ask
.03 x4 doms,pert,etmm,puma
unreal thin man !!!
nice find !!!!
gl
.01
Wow , not me,
i forgot about it ((
hope you have i lot of !!!!!
who's buying?
last 10Q showed $91.4M in NOLs
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
78
|
Created
|
01/04/09
|
Type
|
Free
|
Moderators |
A development-stage biotechnology company engaged in research and development of products and processes to treat medical indications such as cardiovascular disease and viral infections.
http://www.lipidsciences.com/
Lipid Sciences, Incorporated
7068 Koll Center Parkway
Suite 401
Pleasanton, CA 94566
P: (925) 249-4000
F: (925) 249-4040
Authorized Shares: 75,000,000
Source: 10-Q ( 05/12/2004 )
Outstanding Shares: 37,125,348
Source: MGFS ( 07/31/2008 )
Fiscal Year End: December 31
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |